Cancer Clinical Trials Enrollment

Access to clinical trials is an important part of cancer treatment. However, only about 2-3% of all patients diagnosed with cancer enroll in clinical trials. This study will evaluate sociodemographic, clinical, and structural predictors of enrollment into an interventional clinical trial for adult KPNC members diagnosed with any stage of a hematologic or solid tumor between 2017 and 2023. Understanding current patient, provider, and site-specific gaps in enrollment will allow for the development of targeted interventions to streamline and increase trial enrollment.

2